 |
인쇄하기
취소
|
Suspension of Glivec’s patient assistance program under fire from patients
The suspension of Glivec’s assistance program for people suffering from chronic myelogenous leukemia (CML) has sparked outrage and disappointment.
In a meeting with CML patients on May 13, Novartis Korea informed them of their intention to suspend the program from July, citing the launching of Glivec’s generic drugs.
The cuts will likely save the company about 6 to 10 billion won a year a...
In a meeting with CML patients on May 13, Novartis Korea informed them of their intention to suspend the program from July, citing the launching of Glivec’s generic drugs.
The cuts will likely save the company about 6 to 10 billion won a year a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.